Oligonucleotide CDMO Market to Hit US$6.73 Billion by 2029 with 21.8% CAGR | Growth and outlook
The global Oligonucleotide CDMO Market, valued at US$2.33 billion in 2023, is forecasted to grow at a robust CAGR of 21.8%, reaching US$2.51 billion in 2024 and an impressive US$6.73 billion by 2029. Rising outsourcing of development and manufacturing to CDMOs and growing focus on precision/personalized medicine are some of the factors driving the market’s...
Drug Discovery Technologies Market to Reach $51.51 Billion by 2030
The global Drug Discovery Technologies Market is projected to grow from USD 30.58 billion in 2025 to USD 51.51 billion by 2030, registering a CAGR of 11.0% during the forecast period. This growth is being propelled by the increasing outsourcing of drug research and development processes, alongside the rising adoption of advanced technologies aimed at improving drug discovery...
Preimplantation Genetic Testing : Driven by IVF Demand and Advances in Genetic Screening
The global Preimplantation Genetic Testing (PGT) Market is projected to grow from USD 690.2 million in 2025 to USD 1,135.0 million by 2030, registering a CAGR of 10.5% during the forecast period. The market is witnessing strong growth due to rising infertility rates, increasing prevalence of genetic disorders, and expanding adoption of assisted reproductive...
Gene Transfer Technologies Market to Reach $5.93 Billion by 2029
The global Gene Transfer Technologies Market is projected to grow from USD 3.73 billion in 2024 to USD 5.93 billion by 2029, registering a CAGR of 9.7% during the forecast period. Market growth is fueled by increasing adoption of personalized medicine, expanding applications in gene therapy, and rising investments in biotechnology and advanced therapeutics
Download...
Single-Use Bioprocessing Market to Reach $33.67 Billion by 2030 | Growth, Trends & Opportunities
The global single-use bioprocessing market is projected to grow from USD 18.01 billion in 2025 to USD 33.67 billion by 2030, registering a CAGR of 13.3% during the forecast period. This rapid expansion is driven by the increasing adoption of single-use technologies among CDMOs and CMOs, rising demand for cost-efficient production, reduced risk of cross-contamination, and lower capital investment requirements.
Market...
Mice Model Market to Reach $2.74 Billion by 2030
The global Mice Model Market is projected to grow from USD 1.70 billion in 2025 to USD 2.74 billion by 2030, registering a CAGR of 10.0% during the forecast period. Growth is being fueled by increasing reliance on mice models in preclinical research, rising adoption of mouse clinical trials (MCTs), and expanding applications in personalized medicine—particularly in oncology.
Download...
Human Organoids Market to Reach $2.33 Billion by 2029
The global Human Organoids Market is gaining significant strategic traction as life sciences organizations accelerate the shift toward more predictive, ethical, and cost-efficient research models. Valued at USD 1.19 billion in 2024, the market is projected to reach USD 2.33 billion by 2029, growing at a CAGR of 14.4% during the forecast period. This growth underscores a critical transformation...
Humanized Mouse and Rat Model Market: Accelerating Drug Discovery and Precision Medicine Growth
The global humanized mouse and rat model market is witnessing strong momentum, driven by the increasing complexity of drug discovery and the rising demand for personalized medicine. Valued at approximately USD 255.8 million in 2024, the market is projected to reach USD 409.8 million by 2030, expanding at a CAGR of 8.2%. This growth reflects the expanding role of advanced preclinical models in improving...